Several other H3R antagonists are in different stages of development as potential therapies for EDS, schizophrenia, Alzheimer’s disease, ADHD, neuropathic pain, and allergies as shown in Table 3. The gene discussed is HRH3; the disease is early-onset autosomal dominant Alzheimer disease.